Up next

Autoplay

US Approves First Drug Developed To Prevent Chronic Migraines

2 Views • 08/29/25
Share
Side Effects
Side Effects
Subscribers
0

In one study, patients given Aimovig saw their migraine days cut from eight to four a month, on average. Lisa Sigell reports.

Show more
0 Comments sort Sort By

Up next

Autoplay